Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2002):
Free Full Text!
See links below

Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders.

Full Abstract

OBJECTIVE:
In subjects with mood disorders, positron emission tomography (PET) with [(18)F]fluorodeoxyglucose has shown prefrontal cortical metabolism deficits, including in a subgenual region in subjects with familial illness. The authors applied a dl-fenfluramine challenge method to study metabolic response in this region to serotonergic challenge in familial major depression.

METHOD:
The study group consisted of 19 depressed subjects with major depressive disorder or bipolar disorder, all of whom had at least one first-degree relative with history of major depression, and 10 healthy volunteers with similar age and gender distributions. PET images were acquired under placebo and challenge conditions, and volumetric MRI scans were also obtained. Group comparisons of metabolic and volumetric data were performed. Ratings of acute mood change during serotonergic challenge were compared with the imaging data.

RESULTS:
Within Brodmann's area 32, a glucose metabolism deficit in the depressed subjects on placebo day was observed by voxel-level analysis, but no volumetric deficit was found in the subgenual regions examined. Under challenge, both groups suppressed metabolism similarly. Within the patient group, the correlation between acute mood improvement during challenge and greater metabolic suppression approached significance.

CONCLUSIONS:
In familial mood disorders, a ventromedial prefrontal cortical deficit in baseline metabolism is not due to altered structural volume, and the response to serotonergic challenge appears predictive of acute mood response. The potential to predict treatment response can be tested by a combined challenge and treatment study.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Kegeles, Lawrence S (LS); Malone, Kevin M (KM); Slifstein, Mark (M); Ellis, Steven P (SP); Xanthopoulos, Eric (E); Keilp, John G (JG); Campbell, Carl (C); Oquendo, Maria (M); Van Heertum, Ronald L (RL); Mann, J John (JJ);

Affiliation: Department of Psychiatry, Columbia University, New York, NY, USA. lsk5@columbia.edu

Grants: MH-40695 (Agency:United States NIMH) ; MH-46745 (Agency:United States NIMH) ; RR-00645 (Agency:United States NCRR)

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.

Journal: The American journal of psychiatry (Am J Psychiatry), published in United States. (Language: eng)

Reference: 2003-Jan; vol 160 (issue 1) : pp 76-82

Dates: Created 2002/12/30; Completed 2003/01/30; Revised 2007/11/14;

PMID: 12505804, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Blood Glucose (0) ; Fenfluramine (458-24-2) ; Serotonin (50-67-9) ; Fluorodeoxyglucose F18 (63503-12-8)

Related articles

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 - All rights reserved. Terms of Use | Contact Us | Index